Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zongyang Yu

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|January 10, 2013
Applied research on serum protein fingerprints for prediction of Qi deficiency syndrome and phlegm and blood stasis in patients with non-small cell lung cancerZhizhen Liu, Zongyang Yu, Xuenong Ouyang, et al.
Frontiers in Immunology|December 26, 2025
Prognostic Significance of baseline systemic inflammation markers in PD-L1-negative advanced non-small cell lung cancer patients treated with the BRICS sequential regimenJianxin Chen, Ming Lin, Jian Wang, et al.
Plos One|April 15, 2022
Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILKHeping Zhang, Jingfang Wang, Taoyuan Yu, et al.
Emergency Medicine International|July 18, 2022
Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung CancerWencui Kong, Zongyang Yu, Wenwu Wang, et al.
Journal of Cancer Research and Clinical Oncology|April 19, 2023
Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent managementRuishan Wen, Ying Chen, Jinyu Long, et al.
Current Gene Therapy|May 8, 2026
An Epithelial-Mesenchymal Transition-Based Prognostic Model for Survival Prediction in Lung Adenocarcinoma: COL5A2 and ZEB2Peng Zhang, Pan Zhang, Chao Tao, et al.
Clinical Lung Cancer|December 18, 2018
De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective StudyZhengbo Song, Hong Wang, Zongyang Yu, et al.
Frontiers in Medicine|January 8, 2025
Fecal microbiota transplantation in severe pneumonia: a case report on overcoming pan-drug resistant <i>Klebsiella pneumoniae</i> infectionLiying Zhuang, Yanjing You, Shenyuan Zeng, et al.
Journal of Translational Medicine|February 23, 2019
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective studyWenxian Wang, Hong Wang, Peihua Lu, et al.
Frontiers in Immunology|January 26, 2026
Integrating zinc homeostasis network and immune landscape: a five-gene prognostic framework for precision oncology in lung adenocarcinomaFeng Cheng, Jinhe Xu, Wenting Zhang, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|January 10, 2013
Applied research on serum protein fingerprints for prediction of Qi deficiency syndrome and phlegm and blood stasis in patients with non-small cell lung cancerZhizhen Liu, Zongyang Yu, Xuenong Ouyang, et al.
Frontiers in Immunology|December 26, 2025
Prognostic Significance of baseline systemic inflammation markers in PD-L1-negative advanced non-small cell lung cancer patients treated with the BRICS sequential regimenJianxin Chen, Ming Lin, Jian Wang, et al.
Plos One|April 15, 2022
Silencing LncRNA CASC9 inhibits proliferation and invasion of colorectal cancer cells by MiR-542-3p/ILKHeping Zhang, Jingfang Wang, Taoyuan Yu, et al.
Emergency Medicine International|July 18, 2022
Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung CancerWencui Kong, Zongyang Yu, Wenwu Wang, et al.
Journal of Cancer Research and Clinical Oncology|April 19, 2023
Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent managementRuishan Wen, Ying Chen, Jinyu Long, et al.
Current Gene Therapy|May 8, 2026
An Epithelial-Mesenchymal Transition-Based Prognostic Model for Survival Prediction in Lung Adenocarcinoma: COL5A2 and ZEB2Peng Zhang, Pan Zhang, Chao Tao, et al.
Clinical Lung Cancer|December 18, 2018
De Novo MET Amplification in Chinese Patients With Non-Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective StudyZhengbo Song, Hong Wang, Zongyang Yu, et al.
Frontiers in Medicine|January 8, 2025
Fecal microbiota transplantation in severe pneumonia: a case report on overcoming pan-drug resistant <i>Klebsiella pneumoniae</i> infectionLiying Zhuang, Yanjing You, Shenyuan Zeng, et al.
Journal of Translational Medicine|February 23, 2019
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective studyWenxian Wang, Hong Wang, Peihua Lu, et al.
Frontiers in Immunology|January 26, 2026
Integrating zinc homeostasis network and immune landscape: a five-gene prognostic framework for precision oncology in lung adenocarcinomaFeng Cheng, Jinhe Xu, Wenting Zhang, et al.
Pageof 8